Palacios Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Palacios Wealth Management's BMY Position: Q2 2026 in Review
Palacios Wealth Management reduced its Bristol-Myers Squibb (BMY) stake by 4.9% in Q2 2026, selling an estimated $17.3K and leaving 5,866 shares worth $338K. The position accounts for 0.2% of the portfolio, ranked #56.
Palacios Wealth Management first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $477K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Palacios Wealth Management held 5,866 shares of Bristol-Myers Squibb worth $338K as of Q2 2026.
- Palacios Wealth Management sold 301 Bristol-Myers Squibb shares in Q2 2026, an estimated $17.3K.
- Bristol-Myers Squibb made up 0.2% of Palacios Wealth Management's portfolio in Q2 2026, its #56 holding.
- Palacios Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
- Palacios Wealth Management's Bristol-Myers Squibb position peaked at $477K in Q1 2025.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Palacios Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.